Harpoon Therapeutics Inc
Change company Symbol lookup
Select an option...
HARP Harpoon Therapeutics Inc
VIRC Virco Mfg Corp
RVLP RVL Pharmaceuticals PLC
TRGP Targa Resources Corp
RCRT Recruiter.Com Group Inc
VGAS Verde Clean Fuels Inc
DHHC DiamondHead Holdings Corp
EJH E-Home Household Service Holdings Ltd
FLGC Flora Growth Corp
HL Hecla Mining Co
Go

Health Care : Biotechnology | Small Cap Value

Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company. The Company is engaged in the developing a T cell engager that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. It is developing a pipeline of T cell engagers using its TriTACs, focused on the treatment of solid tumors and hematologic malignancies. It has also nominated its clinical candidate using its ProTriTAC platform, a prodrug version of its TriTAC platform, designed to expand the target space for T cell engagers and bring the benefits of TriTACs to the patients. The Company’s TriTAC product candidates include HPN328, HPN217 and HPN536. The Company’s ProTriTAC product candidate include HPN601. T cell engagers are engineered proteins that direct a patient’s own T cells to kill target cells that express specific proteins, or antigens, carried by the target cells.

Closing Price: $0.6725

Day's Change: -0.0145 (-2.11%)

Bid: --

Ask: --

B/A Size: --

Day's High: 0.6997

Day's Low: 0.631

Volume (Average) Volume: 344,365 10-day average volume: 328,263: 344,365

CBRE Group Inc. Cl A Stock Rises Friday, Outperforms Market

4:44 pm ET January 6, 2023 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of CBRE Group Inc. Cl A (CBRE) rallied 3.17% to $80.92 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 2.28% to 3,895.08 and the Dow Jones Industrial Average rising 2.13% to 33,630.61. CBRE Group Inc. Cl A closed $26.75 short of its 52-week high ($107.67), which the company achieved on January 13th.

Trading volume (1.1 M) remained 524,634 below its 50-day average volume of 1.6 M.

Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 6, 2023.

(END) Dow Jones Newswires

January 06, 2023 16:44 ET (21:44 GMT)

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for varies.

Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and